Association of Pentraxin and High-sensitive C-reactive Protein As Inflammatory Biomarkers in Patients with Chronic Periodontitis and Peripheral Arterial Disease

Overview

Journal J Indian Soc Periodontol

Date 2018 May 18

PMID 29769764

Citations 3

Authors

Ramanarayana Boyapati

Srikanth Chinthalapani

Arpita Ramisetti

Shyam Sunder Salavadhi

Radhika Ramachandran

Affiliations

Soon will be listed here.

Abstract

Context: Inflammation is a common feature of both peripheral artery disease (PAD) and periodontal disease.

Aim: The aim of this study is to evaluate the relationship between PAD and periodontal disease by examining the levels of inflammatory cytokines, pentraxin-3 (PTX-3), and high-sensitive C-reactive protein from serum.

Materials And Methods: A total of 50 patients were included in this cross-sectional study. Patients were divided into two groups: those with PAD (test group) and those with the non-PAD group (control group) based on ankle-brachial index values. Periodontal examinations and biochemical analysis for PTX-3 and high-sensitive C-reactive protein were performed to compare the two groups.

Statistical Analysis Used: All the obtained data were sent for statistical analyses using SPSS version 18.

Results: In the clinical parameters, there is statistically significant difference present between plaque index, clinical attachment loss, and periodontal inflammatory surface area with higher mean values in patients with PAD having periodontitis. There is statistical significant ( < 0.01) difference in all biochemical parameters ( < 0.05) considered in the study between PAD patients and non-PAD patients with higher mean values of total cholesterol (TC), low-density lipoprotein (LDL), high-sensitive C-reactive protein (hs-CRP), and PTX-3.

Conclusion: PTX-3 and acute-phase cytokine such as hs-CRP can be regarded as one of the best indicators to show the association between the PAD and periodontitis followed by hs-CRP, TC, very LDL (VLDL), and LDL. However, high-density lipoprotein (HDL) is a poor indicator for its association with chronic periodontitis and PAD.

Citing Articles

The Association between High-density Lipoproteins and Periodontitis.

Ehteshami A, Shirban F, Bagherniya M, Sathyapalan T, Jamialahmadi T, Sahebkar A Curr Med Chem. 2023; 31(39):6407-6428.

PMID: 37493158 DOI: 10.2174/0929867331666230726140736.

Association of Serum Minerals, Vitamin D, Total Protein, and Inflammatory Mediators and Severity of Low Back Pain.

Dadkhah P, Hashemi S, Taheri M, Zakeri H Galen Med J. 2021; 9:e1342.

PMID: 34466546 PMC: 8343825. DOI: 10.31661/gmj.v9i0.1342.

Comparison of effectiveness of low-dose aspirin versus omega-3 fatty acids as adjuvants to nonsurgical periodontal therapy in Type II diabetic patients with chronic periodontitis.

Rampally P, Koduganti R, Ganapathi S, Panthula V, Surya P J Indian Soc Periodontol. 2019; 23(3):249-256.

PMID: 31143006 PMC: 6519093. DOI: 10.4103/jisp.jisp_528_18.

References

Mendez M, Scott T, LaMorte W, Vokonas P, Menzoian J, Garcia R . An association between periodontal disease and peripheral vascular disease. Am J Surg. 1998; 176(2):153-7. DOI: 10.1016/s0002-9610(98)00158-5. View

Chen Y, Umeda M, Nagasawa T, Takeuchi Y, Huang Y, Inoue Y . Periodontitis may increase the risk of peripheral arterial disease. Eur J Vasc Endovasc Surg. 2007; 35(2):153-8. DOI: 10.1016/j.ejvs.2007.08.016. View

Williams R, Offenbacher S . Periodontal medicine: the emergence of a new branch of periodontology. Periodontol 2000. 2001; 23:9-12. DOI: 10.1034/j.1600-0757.2000.2230101.x. View

Oppermann R, Weidlich P, Musskopf M . Periodontal disease and systemic complications. Braz Oral Res. 2013; 26 Suppl 1:39-47. DOI: 10.1590/s1806-83242012000700007. View

Garcia R, Henshaw M, Krall E . Relationship between periodontal disease and systemic health. Periodontol 2000. 2001; 25:21-36. DOI: 10.1034/j.1600-0757.2001.22250103.x. View

Aboyans V, Criqui M, Abraham P, Allison M, Creager M, Diehm C . Measurement and interpretation of the ankle-brachial index: a scientific statement from the American Heart Association. Circulation. 2012; 126(24):2890-909. DOI: 10.1161/CIR.0b013e318276fbcb. View

Bansal T, Pandey A, D D, Asthana A . C-Reactive Protein (CRP) and its Association with Periodontal Disease: A Brief Review. J Clin Diagn Res. 2014; 8(7):ZE21-4. PMC: 4149169. DOI: 10.7860/JCDR/2014/8355.4646. View

Lu B, Parker D, Eaton C . Relationship of periodontal attachment loss to peripheral vascular disease: an analysis of NHANES 1999-2002 data. Atherosclerosis. 2008; 200(1):199-205. DOI: 10.1016/j.atherosclerosis.2007.12.037. View

Weber C, Noels H . Atherosclerosis: current pathogenesis and therapeutic options. Nat Med. 2011; 17(11):1410-22. DOI: 10.1038/nm.2538. View

10.

Petersen P, Baehni P . Periodontal health and global public health. Periodontol 2000. 2012; 60(1):7-14. DOI: 10.1111/j.1600-0757.2012.00452.x. View

11.

Pradeep A, Kathariya R, Raghavendra N, Sharma A . Levels of pentraxin-3 in gingival crevicular fluid and plasma in periodontal health and disease. J Periodontol. 2010; 82(5):734-41. DOI: 10.1902/jop.2010.100526. View

12.

Tasdemir Z, Alkan B . Knowledge of medical doctors in Turkey about the relationship between periodontal disease and systemic health. Braz Oral Res. 2015; 29:55. DOI: 10.1590/1807-3107BOR-2015.vol29.0055. View

13.

Kofler S, Nickel T, Weis M . Role of cytokines in cardiovascular diseases: a focus on endothelial responses to inflammation. Clin Sci (Lond). 2004; 108(3):205-13. DOI: 10.1042/CS20040174. View

14.

Rolph M, Zimmer S, Bottazzi B, Garlanda C, Mantovani A, Hansson G . Production of the long pentraxin PTX3 in advanced atherosclerotic plaques. Arterioscler Thromb Vasc Biol. 2002; 22(5):e10-4. DOI: 10.1161/01.atv.0000015595.95497.2f. View

15.

Botti C, Maione C, Dogliotti G, Russo P, Signoriello G, Molinari A . Circulating cytokines present in the serum of peripheral arterial disease patients induce endothelial dysfunction. J Biol Regul Homeost Agents. 2012; 26(1):67-79. View

16.

Blaizot A, Vergnes J, Nuwwareh S, Amar J, Sixou M . Periodontal diseases and cardiovascular events: meta-analysis of observational studies. Int Dent J. 2009; 59(4):197-209. View

17.

Inoue K, Kodama T, Daida H . Pentraxin 3: a novel biomarker for inflammatory cardiovascular disease. Int J Vasc Med. 2012; 2012:657025. PMC: 3278926. DOI: 10.1155/2012/657025. View

18.

Zhou Y, Zhang J, Zhu M, Lu R, Wang Y, Ni Z . Plasma Pentraxin 3 Is Closely Associated with Peripheral Arterial Disease in Hemodialysis Patients and Predicts Clinical Outcome: A 6-Year Follow-Up. Blood Purif. 2015; 39(4):266-73. DOI: 10.1159/000381254. View

19.

Jenny N, Blumenthal R, Kronmal R, Rotter J, Siscovick D, Psaty B . Associations of pentraxin 3 with cardiovascular disease: the Multi-Ethnic Study of Atherosclerosis. J Thromb Haemost. 2014; 12(6):999-1005. PMC: 4055511. DOI: 10.1111/jth.12557. View

20.

Leira Y, Blanco M, Blanco J, Castillo J . [Association between periodontal disease and cerebrovascular disease. A review of the literature]. Rev Neurol. 2015; 61(1):29-38. View